{ "cik": 1623526, "cik_padded": "0001623526", "entityName": "Stoke Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-108362", "filed": "2026-03-16", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 670000.0, "cash": 84220000.0, "eps_diluted": -0.12, "free_cash_flow": 44915000.0, "net_income": -6885000.0, "operating_cash_flow": 45585000.0, "operating_income": -20590000.0, "revenue": 184420000.0, "stockholders_equity": 352457000.0, "total_assets": 418434000.0, "total_liabilities": 65977000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18719162904978479, "net_margin": -0.037333261034594944, "operating_margin": -0.11164732675414815, "revenue_growth_yoy": 4.045000683900971, "roa_avg2y": -0.019956839891650445, "roa_period_end": -0.016454207832059538, "roe_avg2y": -0.02368103350427703, "roe_period_end": -0.01953429780086649 } }, { "accn": "0001193125-26-108362", "filed": "2026-03-16", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 203000.0, "cash": 127983000.0, "eps_diluted": -1.65, "free_cash_flow": -87054000.0, "net_income": -88981000.0, "operating_cash_flow": -86851000.0, "operating_income": -101372000.0, "revenue": 36555000.0, "stockholders_equity": 229021000.0, "total_assets": 271555000.0, "total_liabilities": 42534000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1857209600866296, "revenue_growth_yoy": 3.1634396355353074, "roa_avg2y": -0.3559973354511029, "roa_period_end": -0.32767211062215756, "roe_avg2y": -0.45797326717895137, "roe_period_end": -0.388527689600517 } }, { "accn": "0001193125-26-108362", "filed": "2026-03-16", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1616000.0, "cash": 191442000.0, "eps_diluted": -2.38, "free_cash_flow": -82683000.0, "net_income": -104699000.0, "operating_cash_flow": -81067000.0, "operating_income": -114773000.0, "revenue": 8780000.0, "stockholders_equity": 159565000.0, "total_assets": 228342000.0, "total_liabilities": 68777000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4310281076677216, "revenue_growth_yoy": -0.29222087867795243, "roa_avg2y": -0.432275205456546, "roa_period_end": -0.4585183628066672, "roe_avg2y": -0.6079834153083208, "roe_period_end": -0.6561526650581267 } }, { "accn": "0000950170-25-041170", "filed": "2025-03-18", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3962000.0, "cash": 113556000.0, "eps_diluted": -2.6, "free_cash_flow": -35828000.0, "net_income": -101067000.0, "operating_cash_flow": -31866000.0, "operating_income": -104356000.0, "revenue": 12405000.0, "stockholders_equity": 184849000.0, "total_assets": 256067000.0, "total_liabilities": 71218000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3852766311962737, "roa_avg2y": -0.408407619632596, "roa_period_end": -0.3946896710626515, "roe_avg2y": -0.5020391132216996, "roe_period_end": -0.5467543778976354 } }, { "accn": "0001564590-23-003175", "filed": "2024-03-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1200000.0, "cash": 144895000.0, "eps_diluted": -2.34, "free_cash_flow": -68107000.0, "net_income": -85805000.0, "operating_cash_flow": -66907000.0, "operating_income": -86065000.0, "stockholders_equity": 217777000.0, "total_assets": 238865000.0, "total_liabilities": 21088000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0968329988933634, "roa_avg2y": -0.3196967156616181, "roa_period_end": -0.3592196428945221, "roe_avg2y": -0.3405940201049905, "roe_period_end": -0.39400395817740164 } }, { "accn": "0001564590-23-003175", "filed": "2023-03-06", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1050000.0, "cash": 287308000.0, "free_cash_flow": -43271000.0, "net_income": -52243000.0, "operating_cash_flow": -42221000.0, "operating_income": -53044000.0, "stockholders_equity": 286078000.0, "total_assets": 297925000.0, "total_liabilities": 11847000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04141178280049497, "roa_avg2y": -0.1983880001898704, "roa_period_end": -0.17535621381220107, "roe_avg2y": -0.20467144362651957, "roe_period_end": -0.18261802725130905 } }, { "accn": "0001564590-22-009634", "filed": "2022-03-10", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1635000.0, "cash": 222471000.0, "free_cash_flow": -32690000.0, "net_income": -32325000.0, "operating_cash_flow": -31055000.0, "operating_income": -35678000.0, "stockholders_equity": 224428000.0, "total_assets": 228750000.0, "total_liabilities": 4322000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.01925784661450443, "roa_avg2y": -0.19224536038942694, "roa_period_end": -0.14131147540983607, "roe_avg2y": -0.19620875518974434, "roe_period_end": -0.144032830128148 } }, { "accn": "0001564590-21-011760", "filed": "2021-03-09", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 935000.0, "cash": 105399000.0, "free_cash_flow": -11899000.0, "net_income": -12521000.0, "operating_cash_flow": -10964000.0, "operating_income": -12781000.0, "stockholders_equity": 105068000.0, "total_assets": 107539000.0, "total_liabilities": 2471000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.023518102562150228, "roa_period_end": -0.11643217809352886, "roe_avg2y": -0.2413082022818378, "roe_period_end": -0.11917044199946701 } }, { "accn": "0001564590-20-012202", "filed": "2020-03-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -1292000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-108362", "filed": "2026-03-16", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001623526.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001623526.json" }, "ticker": "STOK" }